表 1. Results from the univariate analysis of the patient outcome in the two groups.

两组结局的单因素分析

Variable	Prognosis		P
	Good (n=53)	Poor (n=68)
CSF: Cerebrospinal fluid; EEG: Electroencephalography; IV: Intravenous; ICU: Intensive care unit.
Sex/case (%)			0.378
Male	23 (43.4)	35 (51.5)
Female	30 (56.6)	33 (48.5)
Age/yr., median (P25, P75)	31 (21, 45)	32 (23, 46)	0.571
Disease duration/case (%)			0.648
Acute or subacute phase (<3 months)	47 (88.7)	62 (91.2)
Chronic phase (≥3 months)	6 (11.3)	6 (8.8)
Clinical characteristics/case (%)
Consciousness disorder	30 (55.6)	59 (86.8)	0.000
Altered behavior	33 (62.3)	55 (80.9)	0.023
Cognitive dysfunction	42 (79.2)	61 (89.7)	0.109
Disturbance of perception	21 (39.6)	30 (44.1)	0.619
Thought disorder	37 (69.8)	55 (80.9)	0.157
Seizure	26 (49.1)	41 (60.3)	0.217
Movement disorder/case (%)	2 (3.8)	12 (17.6)	0.018
Sleep disturbance	36 (67.9)	43 (63.2)	0.591
Emotional ability	20 (37.7)	35 (51.5)	0.132
Autonomic dysfunction	12 (22.6)	8 (11.8)	0.110
Prodrome symptoms	27 (50.9)	37 (54.4)	0.705
Antibody titers/case (%)
CSF			0.063
Negative	9 (17.0)	3 (4.4)
Weakly positive	3 (5.7)	4 (5.9)
Positive	14 (26.4)	17 (25.0)
Strongly positive	27 (50.9)	44 (64.7)
Serum			0.728
Negative	23 (43.4)	30 (44.1)
Weakly positive	10 (18.9)	8 (11.8)
Positive	17 (32.1)	25 (36.8)
Strongly positive	3 (5.7)	5 (7.4)
Auxiliary examination/case (%)
MRI abnormal	31 (58.5)	40 (58.8)	0.934
EEG abnormal	29 (54.7)	42 (61.8)	0.180
Tumor detection	2 (3.8)	8 (11.8)	0.113
Immunotherapy/case (%)			0.093
No	5 (9.4)	1 (1.5)
High-dose steroids or IV immunoglobulin	46 (86.8)	60 (88.2)
High-dose steroids and IV immunoglobulin	2 (3.8)	4 (5.9)
Combined with second-line treatment	0 (0)	3 (4.4)
Transfer to ICU/case (%)	0 (0)	7 (10.3)	0.016
Mechanical ventilation/case (%)	1 (1.9)	13 (19.1)	0.003